Pathogenesis of Primary Biliary Cirrhosis

Mackay, 1958, Primary biliary cirrhosis showing a high titre of autoantibody: report of a case study, N Engl J Med, 258, 185, 10.1056/NEJM195801232580407 Yeaman, 1988, Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens, Lancet, 1, 1067, 10.1016/S0140-6736(88)91894-6 Jones, 2007, Pathogensis of primary biliary cirrhosis, Gut, 56, 1615 Mutimer, 1989, Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis, Hepatology, 10, 403, 10.1002/hep.1840100402 Kikucki, 2005, Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis, Gastroenterology, 128, 304, 10.1053/j.gastro.2004.11.005 Jones, 1999, Familial primary biliary cirrhosis reassessed: a geographically-based population study, J Hepatol, 30, 402, 10.1016/S0168-8278(99)80097-X Watt, 2004, Patterns of autoimmunity in PBC patients and their families, QJM, 97, 397, 10.1093/qjmed/hch078 Lazaridis, 2007, Increased prevalence of anti-mitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis, Hepatology, 46, 785, 10.1002/hep.21749 Invernizzi, 2005, From bases to basis: linking genetics to causation in primary biliary cirrhosis, Clin Gastroenterol Hepatol, 3, 401, 10.1016/S1542-3565(04)00678-0 Liermann Garcia, 2001, Transplantation for primary biliary cirrhosis:retrospective analysis of 400 patients in a single centre, Hepatology, 33, 22, 10.1053/jhep.2001.20894 Joplin, 1994, Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis, Hepatology, 19, 1375, 10.1002/hep.1840190610 Palmer, 2002, The immunology of primary biliary cirrhosis: the end of the beginning, Clin Exp Immunol, 129, 191, 10.1046/j.1365-2249.2002.01948.x Yeaman, 2000, Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis, Immunol Rev, 174, 238, 10.1034/j.1600-0528.2002.00021h.x Van de Water, 1988, Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function, J Immunol, 141, 2321, 10.4049/jimmunol.141.7.2321 Palmer, 1999, Characterisation of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis, Hepatology, 30, 21, 10.1002/hep.510300106 Quinn, 1993, Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment, Hepatology, 18, 1384, 10.1002/hep.1840180616 Koike, 1998, Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterisation of the autoantigenic region and effects of enzymatic delipoylation and relipoylation, Hepatology, 27, 1467, 10.1002/hep.510270602 Bruggraber, 2003, Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis, Gastroenterology, 125, 1705, 10.1053/j.gastro.2003.09.034 Shimoda, 1995, HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease, J Exp Med, 181, 1835, 10.1084/jem.181.5.1835 Jones, 1995, T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis, Hepatology, 21, 995 Shimoda, 1998, Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis, J Clin Invest, 102, 1831, 10.1172/JCI4213 Kita, 2002, Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis, J Clin Invest, 109, 1231, 10.1172/JCI0214698 Kita, 2002, Identification of HLA-A2-restricted CD8+ cytotoxic T-cell responses in primary biliary cirrhosis: T-cell activation is augmented by immune complexes cross-presented by dendritic cells, J Exp Med, 195, 113, 10.1084/jem.20010956 Robe, 2005, A Key role for autoreactive B-cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex, Hepatology, 41, 1106, 10.1002/hep.20642 Joplin, 1992, Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis, Lancet, 339, 93, 10.1016/0140-6736(92)91001-O Inamura, 2006, Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelail cells do not show primary biliary cirrhosis, Clin Exp Immunol, 145, 93, 10.1111/j.1365-2249.2006.03090.x Kisand, 1994, Enzyme -linked immunosorbent assays for the determination of IgG, IgA, and IgM autoantibodies to pyruvate dehydrogenase in primary biliary cirrhosis, Int J Clin Lab Res, 24, 98, 10.1007/BF02593908 Jones, 1999, Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis a murine model of primary biliary cirrhosis, Hepatology, 30, 65, 10.1002/hep.510300123 Jones, 2002, Investigation of a mechanism for accelerated breakdown of immune-tolerance to the primary biliary cirrhosis associated autoantigen,pyruvate dehydrogenase complex, Lab Invest, 82, 211, 10.1038/labinvest.3780413 Jones, 2006, Adopotive transfer of self-PDC-reactive T-cells into naive mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC), J Hepatol, 44, S10, 10.1016/S0168-8278(06)80021-8 Irie, 2006, NOD.c3c4 congenic mice develop autoimmune liver disease that serologically and pathogenetically models human primary biliary cirrhosis, J Exp Med, 203, 1209, 10.1084/jem.20051911 Oertelt, 2006, Anti-mitochondrial antibodies and primary biliary cirrhosis, J Immunol, 177, 1655, 10.4049/jimmunol.177.3.1655 Wakabayashi K, Lian ZX, Moritoki Y, et al. IL-2 receptor alpha (-/-) mice and the development of primary biliary cirrhosis. Hepatology 44:1240–9. Gershwin, 2007, NOD.2445 mice, a spontaneous model of human primary biliary cirrhosis, develop specific autoreactive T cells, Hepatology, 46, 543A Leung, 2007, Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization, J Immunol, 179, 2651, 10.4049/jimmunol.179.4.2651 Lan, 2006, Liver-targeted and peripheral blood alterations of regulatroy T-cells in primary biliary cirrhosis, Hepatology, 43, 729, 10.1002/hep.21123 Teoh, 1994, Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry, Hepatology, 19, 1029, 10.1002/hep.1840190431 Long, 2001, Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis, J Immunol, 167, 2956, 10.4049/jimmunol.167.5.2956 Walden, 2007, Substrate promiscuity in the pyruvate dehydrogenase complex (PDC) lipoylation pathway:xenobiotic incorporation as a potential mechanism for the pathogenesis of primary biliary cirrhosis, Hepatology, 46, 545A Prince, 2001, The geographical distribution of primary biliary cirrhosis in a well-defined cohort, Hepatology, 34, 1083, 10.1053/jhep.2001.29760 Ala, 2006, Increased prevalence of primary biliary cirrhosis near Superfund waste sites, Hepatology, 43, 525, 10.1002/hep.21076 Pasare, 2003, Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells, Science, 299, 1033, 10.1126/science.1078231 Mao, 2005, Altered monocyte responses to defined TLR ligands in patient with primary biliary cirrhosis, Hepatology, 42, 802, 10.1002/hep.20859 Moritoki, 2007, AMA propduction in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers, Hepatology, 45, 314, 10.1002/hep.21522 Haruta, 2006, Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis, Autoimmunity, 39, 129, 10.1080/08916930600623841 Sadamoto, 1998, Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis, Lancet, 352, 1595, 10.1016/S0140-6736(05)61042-2 Xu, 2003, Does a betaretrovirus infection trigger primary biliary cirrhosis?, Proc Natl Acad Sci U S A, 100, 8454, 10.1073/pnas.1433063100 Xu, 2004, Cloning the human betaretrovirus proviral genome form patients with primary biliary cirrhosis, Hepatology, 39, 151, 10.1002/hep.20024 Selmi, 2004, Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology, 127, 493, 10.1053/j.gastro.2004.05.033 Klein, 1993, Sera from patients with tuberculosis recognise the M2a-epitope (E2-subunit of pyruvate dehydrogenase complex) specific for primary biliary cirrhosis, Clin Exp Immunol, 92, 308, 10.1111/j.1365-2249.1993.tb03397.x Butler, 1993, M2 mitochondrial antbodies and urinary rough mutant bacteris in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria, J Hepatol, 17, 408, 10.1016/S0168-8278(05)80225-9 Kuroki, 1996, Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis, Virchows Arch, 429, 119, 10.1007/BF00192434 Harada, 1997, Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis, Hepatology, 26, 1399, 10.1002/hep.510260604 Tinmouth, 2002, Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis, Liver, 22, 228, 10.1046/j.0106-9543.2002.01595.x Martinez, 1995, Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis, Hepatology, 21, 113 Rodrigues, 1998, A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation, J Clin Invest, 101, 2790, 10.1172/JCI1325 Paumgartner, 2002, Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited, Hepatology, 36, 525, 10.1053/jhep.2002.36088 Ballardini, 2001, Bile duct apoptosis is a rare event in primary biliary cirrhosis, Dig Liver Dis, 33, 151, 10.1016/S1590-8658(01)80071-2 Onori, 2007, Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis, J Histochem Cytochem, 55, 327, 10.1369/jhc.6R7125.2006 Aboutwerat, 2003, Oxidant stress is a significant feature of primary biliary cirrhosis, Biochim Biophys Acta, 1637, 142, 10.1016/S0925-4439(02)00225-9 Jung, 2007, Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis, Hepatology, 45, 1091, 10.1002/hep.21660 Lee, 2006, The epithelial-mesenchymal transition: new insights in signaling, development, and disease, J Cell Biol, 172, 973, 10.1083/jcb.200601018 Wasilenko, 2007, New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast, Hepatology, 45, 837, 10.1002/hep.21644 Xia, 2006, Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation, Am J Pathol, 168, 1500, 10.2353/ajpath.2006.050747 Sicklick, 2006, Evidence for epithelial to mesenchymal transition in adult liver cells, Am J Physiol Gastrointest Liver Physiol, 291, G575, 10.1152/ajpgi.00102.2006 Rygiel, 2006, Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases, J Hepatol, 44, S241, 10.1016/S0168-8278(06)80650-1 Robertson, 2007, Biliary epithelial-mesenchymal transtion in post-transplantation recurrence of primary biliary cirrhosis, Hepatology, 45, 977, 10.1002/hep.21624 Rygiel, 2008, Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease, Lab Invest, 88, 112, 10.1038/labinvest.3700704 Kuroiwa, 2006, Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease, Arthritis Res Ther, 8, R123, 10.1186/ar2012 Sasaki, 2006, Augmented expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis, Virchows Archiv, 449, 462, 10.1007/s00428-006-0257-7 Matsumura, 2002, Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydroganse complex-E2 by apoptosis-related proteases, Hepatology, 35, 14, 10.1053/jhep.2002.30280 Odin, 2001, Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis, J Clin Invest, 108, 223, 10.1172/JCI200110716 Richardson, 2007, Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductual reaction, Gastroenterology, 133, 80, 10.1053/j.gastro.2007.05.012 Theise, 2007, The tissue biology of ductular reactions in human chronic liver disease, Gastroenterology, 133, 350, 10.1053/j.gastro.2007.05.040